Disc Medicine, Inc. (IRON)
NASDAQ
Closed
Oct 22, 2026
Day's Range
75.2552 wk Range
40.00Overview - IRON - Disc Medicine, Inc.
Key Statistics
Valuation
Enterprise Value
1.69B
P/E (Trailing)
4.98
P/E (Forward)
-8.58
PEG Ratio
-1.96
Price / Book
3.61
EV / EBITDA
-6.31
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-23.96%
Return on Equity
-39.08%
Ownership
Shares Outstanding
38.34M
Float
32.91M
Short % of Shares Outstanding
21.89%
Held by Insiders
7.83%
Held by Institutions
114.11%
Price stats
Beta
2.11
50-Day Avg
74.14
200-Day Avg
71.39
Analyst Consensus
13 analysts
Average price target
$ 103.17Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IRON - Disc Medicine, Inc.
Peers - IRON - Disc Medicine, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- IRONNASDAQDisc Medicine, Inc.2.33BMarket Cap-11.07%52-week change4.99P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.03BMarket Cap-23.08%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.82BMarket Cap+8.90%52-week change17.26P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - IRON - Disc Medicine, Inc.
About
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases. The company’s work centers on red blood cell biology, with programs designed to address disorders involving heme biosynthesis and iron homeostasis. Its current pipeline includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
